TICKERNERD
Menu
OMDAOMDAHealthcare · Health Information Services

OMDA Stock Forecast: Omada Health, Inc. Price Predictions for 2026-2027

Last close, 4 Nov 2026
$19
+4.57% on the day

The 12 Wall Street analysts covering Omada Health, Inc. hold a median 12-month price target of $28 — +44.1% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 80 of 100 as at 4 Nov 2026 — inside the top quartile. Here, the model and the Street point the same way.

Market cap
$1.2B
Ticker Nerd rank
80/ 100
Median analyst target
$28
Analysts covering
12
Revenue$87.8M+43.1% y/y
Operating income$3.5M
Net income$5.3M
Free cash flow$2.3M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
+1.3%
1M
−4.6%
YTD
+23.1%
1Y
−23.4%
From 52W high
−23.4%
From 52W low
+77.6%
$11
$25
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

OMDA stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Omada Health, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 4 Nov 2026
80/ 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Growth
89
Issuance
80
Revisions
76
Quality
72
Accruals
69
Momentum
50
Value
44
Size
42
Volatility
23

Growth (89): Sales and profits are climbing, and climbing faster than before.

Volatility (23): The share price moves around a lot.

Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.

Wall Street

OMDA stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on OMDA, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$10$15$20$25$30$35Jan 26Apr 26Jul 26Oct 26OMDAHigh $35Median $28Low $22

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says12 analysts
10 Buy2 Hold0 Sell
Low $22Median $28High $35

The green dot is the last close — the median target sits +44.1% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 5 moved their price target up and 1 moved it down.

DateFirmActionRatingTarget
28 Oct 2026BarclaysMaintainsOverweight$27 → $24
14 Oct 2026Freedom Capital MarketsMaintainsBuy$35
14 Oct 2026Freedom Capital MarketsMaintainsBuy—
14 Sept 2026Freedom Capital MarketsMaintainsBuy$35
14 Sept 2026Freedom Capital MarketsMaintainsBuy—
11 Sept 2026BarclaysMaintainsOverweight$25 → $27
11 Sept 2026BarclaysMaintainsOverweight—
11 Sept 2026BTIGReiteratesBuy—
11 Sept 2026BTIGReiteratesBuy$35
11 Sept 2026NeedhamReiteratesBuy—
11 Sept 2026NeedhamReiteratesBuy$28
14 Aug 2026CitizensMaintainsMarket Outperform—
14 Aug 2026CitizensMaintainsMarket Outperform$27 → $32
14 Aug 2026JP MorganMaintainsOverweight—
14 Aug 2026JP MorganMaintainsOverweight$26 → $30
12 Aug 2026BairdMaintainsNeutral—
12 Aug 2026BairdMaintainsNeutral$15 → $25
10 Aug 2026BTIGMaintainsBuy$30 → $35
10 Aug 2026BTIGMaintainsBuy—
3 Aug 2026BarclaysMaintainsOverweight—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

OMDA appears in the Radar on the weeks it earns a place.

  • Market Radar, every Monday: the week's biggest rank moves across ~4,600 US stocks, and the reason for each.
  • The AI build-out map, free: every AI company we track, part by part, and one part in full with each verdict.

Free. Unsubscribe any time.

The AI build-out map
PDF

  • AI cloud capacity

    MSFTAMZNGOOGLORCL

  • AI chips

    NVDAAVGOAMDMU

  • AI networking and serversIn full

    ANETDELLLITECRDO

  • Data centre power

    VRTCEGGEVVST

Performance

OMDA vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 4 Nov 2026, Omada Health, Inc. returned −23.4% against +14.8% for the S&P 500, dividends included.

OMDA vs S&P 500, last 12 monthsTotal return, rebased to 100
406080100120Jan 26Apr 26Jul 26Oct 26OMDAS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

OMDA analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingThis fiscal year
EPS revision, 90 days
+38.9%
Analysts raising
5
Analysts cutting
0
Fundamentals

Omada Health, Inc. (OMDA) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
81.0×

Cheaper than 9% of US stocks

Price / sales
3.8×

Cheaper than 31% of US stocks

Price / book
4.7×

Cheaper than 20% of US stocks

EV / EBITDA
168.6×

Cheaper than 1% of US stocks

Growth & margins
Revenue growth (YoY)
43.1%

Higher than 84% of US stocks

Earnings growth (YoY)
43.1%

Higher than 72% of US stocks

Gross margin
72.6%

Higher than 85% of US stocks

Operating margin
4.0%

Higher than 52% of US stocks

Net margin
1.4%

Higher than 50% of US stocks

Returns & dividend
Return on equity
1.8%

Higher than 47% of US stocks

Return on assets
−0.1%

Higher than 43% of US stocks

Dividend yield
0.0%

Higher than 1% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Omada Health, Inc. (OMDA) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Omada Health, Inc. has a market value of $1.2B and an enterprise value of $915.7M.

  • Revenue in the twelve months to 30 June 2026: $309.8M. The latest quarter grew 43.1% year on year.

  • Net income over the same four quarters: $4.3M, a 1.4% net margin.

  • Diluted earnings per share, trailing twelve months: $0.05.

  • Free cash flow in the twelve months to 30 June 2026: $17.1M, after $5.6M of capital spending.

  • Shares outstanding: 60.6M.

  • Trailing P/E: 81.0×; forward P/E: 34.9× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Forward dividend yield: 0.00%, paying out 0% of earnings.

  • Omada Health, Inc. employs 946 people — $327K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 4 Nov 2026

Data provided by Twelve Data

Peers

OMDA vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelHealth Information Services
CompanyMarket capTKN rank
OMDAOmada Health, Inc.$1.2B80
GDRXGoodRx Holdings, Inc.$1.3B80
HSTMHealthStream, Inc.$963.6M92
PHRPhreesia, Inc.$794.6M54
TDOCTeladoc Health, Inc.$1.7B86
CERTCertara, Inc.$1.8B65
OMCLOmnicell, Inc.$1.8B98

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Omada Health, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest OMDA news & analysis

Omada Health to Present Peer-Reviewed Research on Improving Weight Loss and Body Composition During GLP-1 Treatment at World Obesity and Weight Management Congress

GlobeNewsWire · 20 Oct 2026positive

Omada Health said it will present peer-reviewed research at WOC 2026 showing members in its GLP-1 Care Track lost more weight and had greater improvements in body composition than GLP-1 users receiving usual care. The findings were published in Diabetes, Obesity and Metabolism.

Why it matters — The research highlights reported outcomes from Omada’s GLP-1 Care Track, a program relevant to the company’s virtual healthcare offering.

Omada Health President Wei-Li Shao Sells 9,418 Shares for $236,000

The Motley Fool · 23 Sept 2026neutral

Omada Health President Wei-Li Shao sold 9,418 shares for approximately $236,000. The open-market sale represented 3% of his direct equity holdings and was conducted under a pre-established Rule 10b5-1 trading plan.

Why it matters — A company president's insider share sale could draw attention from investors monitoring executive activity at Omada Health.

Omada Health, Inc. (OMDA) Analyst/Investor Day Transcript

Seeking Alpha · 11 Sept 2026neutral

Omada Health, Inc. held an Analyst/Investor Day, and Seeking Alpha published the transcript of the event, covering management's discussion with analysts and investors. The transcript provides a record of the company's presentations and remarks from the occasion.

Why it matters — A transcript of the Analyst/Investor Day offers OMDA watchers direct access to management's commentary and the company's stated outlook as presented to investors.

Omada Health to Present Updated Long-Term Financial Targets at Inaugural Investor Day

GlobeNewsWire · 10 Sept 2026neutral

Omada Health announced it will present updated long-term financial targets at its inaugural Investor Day, held today at the Four Seasons Hotel in New York. The virtual-first, between-visit healthcare provider is set to outline these targets to investors at the event.

Why it matters — Omada watchers will learn the company's updated long-term financial targets for the first time at its inaugural Investor Day, which could frame its growth outlook.

FAQ

Frequently asked questions about OMDA stock

What is the OMDA stock price forecast for 2026-2027?

The 12 Wall Street analysts covering Omada Health, Inc. have a median 12-month price target of $28, with estimates ranging from $22 to $35. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is OMDA stock a buy right now?

Of the 12 analysts covering Omada Health, Inc., 10 rate it a Buy, 2 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Omada Health, Inc. 80 out of 100 across roughly 4,600 US stocks as at 4 Nov 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank OMDA?

As at 4 Nov 2026, Omada Health, Inc. ranks 80 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Growth (89 of 100).

Will OMDA stock go up?

No one can know that. What the data says: the median 12-month target from 12 analysts implies +44.1% from the last close, and Ticker Nerd's factor model ranks Omada Health, Inc. 80 out of 100 as at 4 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the OMDA stock forecast for 2030?

No analyst covering Omada Health, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for OMDA are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $22 to $35 over the next 12 months.

How has OMDA stock performed over the past year?

Omada Health, Inc. returned -23.4% over the 12 months to 4 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Omada Health, Inc. do?

Omada Health, Inc. Common Stock represents Omada Health, a digital health company focused on virtual care for chronic condition prevention and management.

What is the latest news on OMDA?

The most recent item we track (GlobeNewsWire, 20 Oct 2026): "Omada Health to Present Peer-Reviewed Research on Improving Weight Loss and Body Composition During GLP-1 Treatment at World Obesity and Weight Management Congress". Omada Health said it will present peer-reviewed research at WOC 2026 showing members in its GLP-1 Care Track lost more weight and had greater improvements in body composition than GLP-1 users receiving usual care. The findings were published in Diabetes, Obesity and Metabolism.

Company

About Omada Health, Inc.

Omada Health, Inc. Common Stock represents Omada Health, a digital health company focused on virtual care for chronic condition prevention and management. The company provides evidence-based programs that combine coaching, connected devices, and digital tools to support people living with prediabetes, diabetes, hypertension, weight management needs, and musculoskeletal conditions. Omada Health works primarily with employers, health plans, pharmacy benefit managers, and health systems, helping them offer scalable care delivery outside traditional clinic settings. Its platform centers on ongoing, between-visit support designed to improve adherence, encourage healthier behaviors, and integrate with broader population health initiatives. Based in South San Francisco, California, Omada Health plays a notable role in the healthcare technology market by delivering virtual-first services that address long-term, high-prevalence conditions through personalized, technology-enabled care.

CEO Mr. Sean P. Duffy · 946 employees · United States · https://www.omadahealth.com